Compare NTAP & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTAP | ALC |
|---|---|---|
| Founded | 1992 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Electronic Components | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.3B | 32.4B |
| IPO Year | 1996 | 2002 |
| Metric | NTAP | ALC |
|---|---|---|
| Price | $165.63 | $66.93 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $116.58 | $89.38 |
| AVG Volume (30 Days) | ★ 2.7M | 1.8M |
| Earning Date | 05-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.91% | 0.25% |
| EPS Growth | ★ 11.99 | N/A |
| EPS | ★ 6.35 | N/A |
| Revenue | ★ $6,237,000,000.00 | N/A |
| Revenue This Year | $6.22 | $7.99 |
| Revenue Next Year | $4.91 | $6.38 |
| P/E Ratio | ★ $25.78 | $38.31 |
| Revenue Growth | ★ 5.59 | N/A |
| 52 Week Low | $93.69 | $61.84 |
| 52 Week High | $192.83 | $92.55 |
| Indicator | NTAP | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 63.42 | 48.50 |
| Support Level | $95.25 | $63.91 |
| Resistance Level | $192.83 | $68.25 |
| Average True Range (ATR) | 6.46 | 1.40 |
| MACD | -0.92 | 0.28 |
| Stochastic Oscillator | 88.78 | 51.22 |
NetApp Inc is storage hardware provider into a software-driven, cloud-centric data infrastructure company. Its flagship ONTAP data management software, together with a comprehensive portfolio of all-flash, hybrid-flash, and cloud-native solutions, forms the backbone of digital transformation for thousands of enterprises world'wide. Its operations are organized into two segments Hybrid Cloud and Public Cloud. It generates majority of revenue from Hybrid Cloud offers a unified data storage portfolio of storage management and infrastructure solutions that helps customers modernize their data centers. Hybrid Cloud includes software, hardware, and related support, along with professional and other services. It generates majority of revenue from United States followed by International market.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.